Related Experiment Video
Updated: Mar 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in
Jannick Prentoe1, Rodrigo Velázquez-Moctezuma1, Steven K H Foung2
1Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Hvidovre Hospital and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Removing the hypervariable region 1 (HVR1) from hepatitis C virus (HCV) envelope proteins E1/E2 simplifies neutralization sensitivity. This suggests HVR1-deleted antigens may be superior for developing effective HCV vaccines.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Hepatitis C virus (HCV) causes millions of new infections annually.
- The genetic diversity of HCV envelope proteins E1 and E2, and shielding by HVR1, hinder universal vaccine development.
Purpose of the Study:
- To investigate the role of HVR1 in HCV neutralization by human monoclonal antibodies (HMAbs).
- To assess the potential of HVR1-deleted HCV antigens as vaccine immunogens.
Main Methods:
- Cultured viruses expressing E1/E2 complexes with and without HVR1 from different HCV genotypes were used.
- Neutralization assays with 12 HMAbs targeting E1, E2, and E1/E2 epitopes were performed.
- HCV pulldown experiments and regression analysis of antibody binding and neutralization titers were conducted.
Main Results:
- HVR1 shielding significantly impacted neutralization sensitivity, with variations observed across genotypes.
- HVR1 deletion reduced intergenotypic neutralization sensitivity differences for most antibodies.
- A simplified neutralization pattern emerged in HVR1-deleted viruses, with some outliers explained by specific amino acid residues in E2.
Conclusions:
- HVR1 complicates HCV neutralization by shielding conserved epitopes.
- HVR1-deleted HCV antigens represent a promising strategy for developing more broadly protective HCV vaccines.
Related Concept Videos
Hepatitis
Viruses with RNA Genomes
Retroviruses
Inhibitors of Viral Protein Synthesis
Cytomegalovirus Disease
Leaky Scanning

